Insulin resistance and the risk of stroke and stroke subtypes in the nondiabetic elderly

American Journal of Epidemiology

Volumn 176, Issue 8, 2012, Pages 699-707

  Wieberdink, Renske G ^a   Koudstaal, Peter J ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   Breteler, Monique M B ^a,b   Arfan Ikram, M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

cerebral infarction; cohort studies; diabetes mellitus; insulin resistance; intracerebral hemorrhage; stroke

Indexed keywords

GLUCOSE; INSULIN;

AGE CLASS; COHORT ANALYSIS; DIABETES; ELDERLY POPULATION; HEALTH RISK; HOMEOSTASIS; HORMONE; NUMERICAL MODEL; PUBLIC HEALTH; RISK FACTOR; STROKE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT;

AGED; BODY MASS INDEX; BRAIN STEM INFARCTIONS; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; COHORT STUDIES; FASTING; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; STROKE;

NETHERLANDS; ROTTERDAM; SOUTH HOLLAND;

EID: 84867739462     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws149     Document Type: Article

References (25)

1. Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108(12): 1527-1532.
2. Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010;55(13):1310-1317.
3. Ruige JB, Assendelft WJ, Dekker JM, et al. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97(10):996-1001.
4. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration. Lancet. 2010;375(9733):2215-2222.
5. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214- E223.
6. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137(9): 959-965.
7. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
8. Lakka HM, Lakka TA, Tuomilehto J, et al. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med. 2000;160(8): 1160-1168.
9. Lawlor DA, Fraser A, Ebrahim S, et al. Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women. PLoS Med. 2007;4(8):e263. (doi:10.1371/journal. pmed.0040263).
10. Lindahl B, Dinesen B, Eliasson M, et al. High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke. 2000;31(12):2936-2941.
11. Nakamura K, Sakurai M, Miura K, et al. Homeostasis model assessment of insulin resistance and the risk of cardiovascular events in middle-aged non-diabetic Japanese men. Diabetologia. 2010;53(9):1894-1902.
12. Pyörälä M, Miettinen H, Laakso M, et al. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke. 1998;29(9):1860-1866.
13. Rasmussen-Torvik LJ, Yatsuya H, Selvin E, et al. Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study). Am J Cardiol. 2010;105(10): 1420-1425.
14. Rundek T, Gardener H, Xu Q, et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol. 2010;67(10): 1195-1200.
15. Hofman A, van Duijn CM, Franco OH, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol. 2011;26(8):657-686.
16. Neeley WE. Simple automated determination of serum or plasma glucose by a hexokinase-glucose-6-phosphate dehydrogenase method. Clin Chem. 1972;18(6):509-515.
17. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5): 541-553.
18. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet. 2002;359(9314): 1309-1310.
19. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens. 1999;17(2):151-183.
20. Wieberdink RG, van Schie MC, Koudstaal PJ, et al. High von Willebrand factor levels increase the risk of stroke: the Rotterdam Study. Stroke. 2010;41(10):2151-2156.
21. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation. 2007;115(17):2340-2343.
22. Tanne D, Tenenbaum A, Boyko V, et al. Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic disease. Eur J Neurol. 2009;16(11):1217-1223.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(suppl 1): S62-S69.
24. Wong TY. Is retinal photography useful in the measurement of stroke risk? Lancet Neurol. 2004;3(3):179-183.
25. Thacker EL, Psaty BM, McKnight B, et al. Fasting and postglucose load measures of insulin resistance and risk of ischemic stroke in older adults. Stroke. 2011;42(12): 3347-3351.